(Press-News.org) DETROIT – Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and rate of progression of neurodegeneration in Alzheimer’s disease. Blood-based NfL is a minimally invasive and easily accessible biomarker, making it a useful clinical biomarker. Youjin Jung and Jessica Damoiseaux, Ph.D., analyzed existing literature to examine the association between serum or plasma NfL and structural/functional brain imaging measures of neurodegeneration from MRI or PET imaging. Jung is a doctoral student in the Behavioral and Cognitive Neuroscience program and a trainee at WSU’s Institute of Gerontology. Damoiseaux is an associate professor in the Institute of Gerontology and the Department of Psychology.
Though NfL levels also increase in typical aging as a non-specific marker of neuronal damage, the levels, as well as the rate of increase, seen in Alzheimer’s dementia are higher. Jung and Damoiseaux concluded that research indicates that high blood levels of NfL reflect the severity of atrophy in several overlapping brain regions, especially the medial temporal lobe. Higher serum NfL is also correlated with more severe brain glucose hypometabolism, as well as diminished white matter integrity, in persons on the Alzheimer’s continuum.
“The cross-sectional literature indicates that blood NfL shows great promise as a monitoring biomarker to indicate the severity of neurodegeneration in Alzheimer’s disease,” Damoiseaux said. “It could be especially useful in persons who show Alzheimer’s pathology but are at present cognitively unimpaired, or in people who are highly likely to develop Alzheimer’s disease due to having the APOE ε4 allele or higher Aβ load.”
Longitudinal studies also consistently found significant relationships between blood NfL and atrophy in brain regions vulnerable to Alzheimer’s disease pathology. “We found that an increase in blood NfL may precede Alzheimer’s disease-related changes in cortical atrophy and may be elevated in the preclinical stages of Alzheimer’s disease,” Damoiseaux said.
The review of the cross-sectional and longitudinal literature showed that blood NfL levels consistently predicted the severity of atrophy and glucose metabolism in brain areas commonly affected by Alzheimer’s pathology. The work by Jung and Damoiseaux highlights that blood NfL is a useful prognostic marker for predicting the progression of neurodegeneration, as well as being a useful marker to assess the risk that a cognitively unimpaired person with a higher risk for Alzheimer’s disease will show abnormal changes in brain structure and function.
Jung warns that there are still knowledge gaps to be filled for the appropriate use of blood NfL as a biomarker. “We need more studies on how blood NfL is related to different aspects of neuronal damage,” she said, “and the field should seek to learn more about potential factors that may affect the NfL concentration in the blood.”
The review article, “The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer’s disease,” is published in the journal Brain, Aug. 4, 2023, doi.org/10.1093/brain/awad267.
END
Blood biomarker shows “great promise” predicting progression to Alzheimer’s disease in at-risk population
2023-09-01
ELSE PRESS RELEASES FROM THIS DATE:
Redo transcatheter aortic valve replacement proven effective, safe
2023-09-01
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
The novel findings, published today in the peer-reviewed journal The Lancet, are significant because recent randomized clinical trials have shown that TAVR is a meaningful treatment option for both younger and lower-risk surgical ...
Inflammation may influence weight loss surgery outcomes, new study reveals
2023-09-01
Research funded by the National Institute for Health and Care Research (NIHR) has shown that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.
Published in Psychological Medicine and led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, this is the first study to investigate the links between depression and inflammation in patients with obesity before and after bariatric surgery. The analysis showed a strong relationship ...
Study shows that low-dose aspirin associated with a 15% lower risk of developing diabetes in people aged over 65 years
2023-09-01
*Note- this is an early release from the Annual Meeting of the European Association for the Study of Diabetes (EASD) meeting in Hamburg, October 2-6. Please credit the meeting if you use this story*
New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) shows that use of low dose (100mg daily) aspirin among older adults aged 65 years and older is associated with a 15% lower risk of developing type 2 diabetes. The authors, led by Professor Sophia Zoungas, School of Public Health and Preventive Medicine, ...
New grant to optimize gut microbes, boost health benefits of broccoli
2023-08-31
URBANA, Ill. — Love it or hate it, broccoli is chock-full of health-promoting chemicals linked to heart health, cancer prevention, immune function, weight management, and more. However, some people are less efficient than others at unlocking those chemical benefits. A research team at the University of Illinois Urbana-Champaign suggests gut microbe communities may be responsible for the variation. With a new grant from the USDA’s National Institute of Food and Agriculture, the team plans to identify which microbes maximize the benefits of broccoli and other brassica ...
Illuminating new horizons: Navigating nonlinear scattering with precision
2023-08-31
In the intricate world of light, a journey through inhomogeneous media often leads to distortions in space, time, spectrum, and polarization. These distortions, detrimental to applications like optical manipulation, imaging, and communication, have long posed a challenge. Enter the art of wavefront shaping (WS) — a potent tool for correcting these wave maladies in linear optics. But that's not all. Nonlinearity adds a twist, finding purpose in fields from biological sensing to phototherapy. Now, picture combining these forces — ...
Digging deeper into how vaccines work against parasitic disease
2023-08-31
COLUMBUS, Ohio – Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.
But in new work, the research team has determined how these vaccine candidates, created using mutated disease-causing parasites, prompt molecular-level changes in host cells that have specific roles in helping generate the immune response.
Despite using the same CRISPR ...
Housing heroes: New program to support veterans experiencing homelessness
2023-08-31
Since 2009, the number of veterans experiencing homelessness across the United States has shrunk by more than 50%, according to a 2022 Department of Housing report.
With the support of a $150,000 grant from the Department of Veterans Affairs (VA), the University of Missouri School of Law Veterans Clinic is aiming to continue this trend here at home with a new program designed to further empower veterans in taking steps out of homelessness.
The Veterans Outreach Program will help attorneys connect with veterans experiencing homelessness with the goal of offering them the legal assistance ...
Mapping the coronavirus spike protein could provide insight into vaccine development
2023-08-31
Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s. In a new study, molecular biologist Steven Van Doren, a scientist in the University of Missouri College of Agriculture, Food and Natural Resources, has uncovered unexpected actions of a key player in how the coronavirus infects its target — a discovery that could guide further vaccine development.
Funded by a National Science Foundation (NSF) grant, Van Doren and his team studied the fusion peptide, an important feature of the spike protein that serves to bind the virus with ...
Dectin-1 stimulation promotes distinct inflammatory signature in HIV and aging
2023-08-31
“To our knowledge, our study is the first to evaluate the specific function of Dectin-1 in the setting of aging and HIV-infection.”
BUFFALO, NY- August 31, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 16, entitled, “Dectin-1 stimulation promotes a distinct inflammatory signature in the setting of HIV-infection and aging.”
Dectin-1 is an innate immune receptor that recognizes and binds β-1, 3/1, 6 glucans on fungi. In this new study, researchers Archit Kumar, Jiawei Wang, Allen Esterly, Chris ...
Excess ceramide and disrupted iron metabolism in neuronal mitochondria found to be the cause for MEPAN syndrome
2023-08-31
A recent study published in Nature Metabolism has revealed the pathogenic mechanism underlying a rare pediatric neurodegenerative disorder known as mitochondrial enoyl reductase protein-associated neurodegeneration (MEPAN) syndrome. The study was led by Dr. Hugo J. Bellen, distinguished service professor at Baylor College of Medicine, and Chair of Neurogenetics at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (Duncan NRI), and Dr. Debdeep Dutta, a postdoctoral fellow in the Bellen lab. The Duncan NRI team found that in patients and animal models of this disorder, a large number of neurons ...